Purchases and Sales Made in Q2 2023 in Chemomab Therapeutics Ltd. (CMMB)
This table provides information about the institutional ownership of Chemomab Therapeutics Ltd. (CMMB) during Q2 2023. The information is specifically focused on institutions that hold shares of Chemomab Therapeutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 08, 2023
Q2 2023
|
Rhumbline Advisers
Boston, MA |
BUY
|
- |
3.01KNew |
$3.01K - $5.53K
|
3.01K
$4.96K
|
|
|
Aug 10, 2023
Q2 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 11, 2023
Q2 2023
|
Ubs Group Ag
|
SELL
|
- |
-399- 97.08% |
$399 - $734
|
12
$19.8
|
|
|
Aug 14, 2023
Q2 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-7.7K- 98.72% |
$7.7K - $14.2K
|
100
$165
|
|
|
Aug 14, 2023
Q2 2023
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-23.3K- 9.85% |
$23.3K - $42.9K
|
213K
$352K
|